Amy Thompson, a senior analyst at Signify Research, explains what she is seeing in the market for radiology PACS and IT systems. She said the biggest overall, strategic technology trends are wider adoption of enterprise imaging, migration to cloud data storage, adoption of artificial intelligence (AI), streamlining workflow, and implementing structured reporting.

PET/MRI achieves similar or superior results to PET/CT for the detection of pulmonary malignancies, according to new research.

DiA Imaging Analysis, an Israel-based healthcare technology company, has gained U.S. Food and Drug Administration (FDA) clearance for LVivo IQS, a new software solution designed to help users acquire high-quality echocardiography images, regardless of their experience.

Contrast-enhanced spectral mammography (CESM) is a cost-effective alternative to MRI for patients with breast cancer and could save facilities potentially tens of thousands of dollars every year.

Older women with a diagnosis of early breast cancer can safely opt out of radiation therapy following surgery, a new analysis indicates.

The vast majority of 500 artificial intelligence (AI) algorithms now cleared for clinical use in the U.S. are for radiology and cardiology. For this reason, cardiologists and radiologists need to learn how these technologies work and realise the clinical use of AI is no longer science fiction.

The ACC/AHA 2021 Chest Pain Assessment Guidelines boosted coronary computed tomography angiography (CCTA) to a Class 1A level of clinical evidence and helped significantly boost interest in building or expanding cardiac CT programs in the past year. While Cardiac CTA does have a large amount of clinical study support, there are some gaps remaining yet...

Private equity investors have started getting more involved in cardiology in recent years, echoing their rise in radiology, dermatology and other specialties.

The integration of artificial intelligence into radiology PACS and enterprise imaging systems has become a big topic of discussion with IT vendors over the past couple years. This has become a bigger question from hospitals and radiology groups as there are now about 400 radiology related AI algorithms that have U.S. Food and Drug Administration...

Risk model-based screening for lung cancer accounting for personal risk may be more cost-effective than age- and smoking history-based screening recommended by the U.S. Preventive Services Task Force (USPSTF), according to a cost-effectiveness analysis.